NEUexp
Neuroanatomía y neuropatología experimental
Publicacions (26) Publicacions en què ha participat algun/a investigador/a
2023
-
Drastic decline in vasoactive intestinal peptide expression in the suprachiasmatic nucleus in obese mice on a long-term high-fat diet
Brain Research Bulletin, Vol. 202
-
Expression of RAD9B in the mesostriatal system of rats and humans: Overexpression in a 6-OHDA rat model of Parkinson's disease
Annals of Anatomy, Vol. 250
-
Morphological study of neuropeptide Y expression in human and mouse anterior insular cortex: Overexpression in the insular cortex and nucleus accumbens in obese mice on a long-term obesogenic diet
Annals of Anatomy, Vol. 250
2022
-
Long-term exposure to GDNF induces dephosphorylation of Ret, AKT, and ERK1/2, and is ineffective at protecting midbrain dopaminergic neurons in cellular models of Parkinson's disease
Molecular and Cellular Neuroscience, Vol. 118
2021
-
Prolonged dopamine D3 receptor stimulation promotes dopamine transporter ubiquitination and degradation through a PKC-dependent mechanism
Pharmacological Research, Vol. 165
2020
-
DRD3 (dopamine receptor D3) but not DRD2 activates autophagy through MTORC1 inhibition preserving protein synthesis
Autophagy, Vol. 16, Núm. 7, pp. 1279-1295
2019
-
Uso Terapéutico de los Cannabinoides en la Enfermedad De Parkinson. Revisión
Majorensis: Revista Electrónica de Ciencia y Tecnología, Núm. 15, pp. 1-8
2018
-
Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease
Experimental Neurology, Vol. 299, pp. 137-147
2016
-
A regulatable AAV vector mediating GDNF biological effects at clinically-approved sub-antimicrobial doxycycline doses
Molecular Therapy - Methods and Clinical Development, Vol. 3, pp. 16027
-
Long-term controlled GDNF over-expression reduces dopamine transporter activity without affecting tyrosine hydroxylase expression in the rat mesostriatal system
Neurobiology of Disease, Vol. 88, pp. 44-54
2015
-
D1 dopamine receptor stimulation impairs striatal proteasome activity in Parkinsonism through 26S proteasome disassembly
Neurobiology of Disease, Vol. 78, pp. 77-87
-
Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake
Neurobiology of Disease, Vol. 74, pp. 325-335
2014
-
Striatal vessels receive phosphorylated tyrosine hydroxylase-rich innervation from midbrain dopaminergic neurons
Frontiers in Neuroanatomy, Vol. 8, Núm. AUG
2012
-
Differential N termini in epithelial Na + channel δ-subunit isoforms modulate channel trafficking to the membrane
American Journal of Physiology - Cell Physiology, Vol. 302, Núm. 6
2010
-
The dopamine transporter is differentially regulated after dopaminergic lesion
Neurobiology of Disease, Vol. 40, Núm. 3, pp. 518-530
-
The neuronal-specific SGK1.1 kinase regulates δ-epithelial Na + channel independently of PY motifs and couples it to phospholipase C signaling
American Journal of Physiology - Cell Physiology, Vol. 299, Núm. 4
-
Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease
Frontiers in Neuroanatomy
2009
-
Aging effects on the dopamine transporter expression and compensatory mechanisms
Neurobiology of Aging, Vol. 30, Núm. 6, pp. 973-986
-
Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease
Neurobiology of Disease, Vol. 36, Núm. 3, pp. 494-508
-
Phenotype, compartmental organization and differential vulnerability of nigral dopaminergic neurons
Journal of Neural Transmission, Supplementa, pp. 21-37